RecruitingACTRN12605000516684
Official study titleA randomised phase IV study to compare two rates of dosage tapering, when switching patients to aripiprazole from other atypical antipsychotics for the treatment of schizophrenia and schizoaffective disorder
Location not clearly listedSchizophreniaInterventional study
- Countries
- Sponsor
- Bristol Meyers Squibb Pharmaceuticals
RecruitingNCT07696000
Official study titleThe Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy
In MedanSchizophreniaInterventional studyAges 18–60
- Countries
- Indonesia
- Sponsor
- DINA KEUMALA SARI
RecruitingNCT06005766
Official study titleDoes Group-Based Metacognitive Skills Training Reduce Jumping to Conclusions Bias of Patients With Psychotic Disorders in the Context of Forensic Psychiatric Care
In VaasaSchizophrenia, DepressionBehavioural studyAges 18+
- Countries
- Finland
- Sponsor
- University of Jyvaskyla
RecruitingNCT06650943
Official study titleEfficacy Study on Nursing Consultation in Weight and Metabolic Syndrome Management Based on the Carbohydrate-insulin Theory in Individuals with First-episode Psychosis (MetaKOP)
In BilbaoSchizophreniaBehavioural study
- Countries
- Spain
- Sponsor
- Hospital de Basurto
RecruitingNCT07616999
Official study titleNavigating the Longitudinal Effects of Early Treatment Strategies and Relapse on Clinical, Cognitive, and Functional Outcomes: A 20-Year Follow-up of First Episode Psychosis
In Hong KongSchizophreniaObservational studyAges 18–65
- Countries
- China
- Sponsor
- The University of Hong Kong
RecruitingNCT06585787
Official study titleA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
Multiple locations, including GilbertSchizophreniaMedication studyAges 55–90
- Countries
- United States, France, Belgium, + 21 others
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
RecruitingNCT07231497
In MinneapolisSchizophreniaMedication studyAges 18–35
- Countries
- United States
- Sponsor
- University of Minnesota
RecruitingNCT04370730
Official study titleDimensional and Developmental Approach to Psychotic Episodes in Children and Adolescents: Impact on Clinical Management
In ParisSchizophreniaInterventional studyAges 7–20
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
RecruitingNCT07427810
Official study titleLongitudinal Follow-up of Psychiatric Symptoms and Functioning in Young Adults With Autism.
In KarlstadSchizophreniaObservational studyAges 20–35
- Countries
- Sweden
- Sponsor
- Värmland County Council, Sweden
RecruitingNCT07680114
Official study titleA Pilot Feasibility Study of Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
In MadisonSchizophreniaDevice studyAges 18–50
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
RecruitingNCT05340348
Official study titleFormation of a Patientheque in Patients With a Beginner Psychosis
In BrestSchizophreniaInterventional studyAges 15–30
- Countries
- France
- Sponsor
- University Hospital, Brest
RecruitingNCT05880719
Official study titlePilot and Descriptive Study of the Effects of the Implementation of Computer Assisted Music Remediation Groups on the Cognitive Functioning of Young Patients Presenting a First Episode Psychosis
In CaenSchizophreniaInterventional studyAges 18–30
- Countries
- France
- Sponsor
- University Hospital, Caen
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.